BEAD BIOPHARMA LIMITEDActive
Key figures
BEAD BIOPHARMA LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025/26Balance sheet structure
Filed accounts2023/24–2025/26
| 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|
| Profit for the year | — | -376,206 | -627,552 |
| Cash at bank and in hand | — | 459,561 | 1,404,502 |
| Total assets | — | 534,060 | 1,501,821 |
| Total liabilities | — | — | — |
| Net assets / total equity | -40,404 | 483,398 | 1,469,961 |
| Average number of employees | 0 | 2 | 3 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: BEAD BIOPHARMA LIMITED
Company
BEAD BIOPHARMA LIMITED is a private limited company registered with Companies House under company number SC763273. It was incorporated on 22 Mar 2023. Its status is active. The registered office is in Aberdeen (AB25). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts (filleted). Loss for the year was £627,552. Net assets were £1,469,961, up 204.1% on the previous year. Cash at bank and in hand was £1,404,502. The company had an average of 3 employees. Figures are available for 3 financial years (2023/24–2025/26).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 4 Apr 2027.